DE60228324D1 - Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem antibakteriellen carbapenem-mittel - Google Patents

Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem antibakteriellen carbapenem-mittel

Info

Publication number
DE60228324D1
DE60228324D1 DE60228324T DE60228324T DE60228324D1 DE 60228324 D1 DE60228324 D1 DE 60228324D1 DE 60228324 T DE60228324 T DE 60228324T DE 60228324 T DE60228324 T DE 60228324T DE 60228324 D1 DE60228324 D1 DE 60228324D1
Authority
DE
Germany
Prior art keywords
gemifloxacin
salt
bacterial infections
agent
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60228324T
Other languages
English (en)
Inventor
Nancy Niconovich
Stephen Rittenhouse
Lynn Mccloskey
Kyong-Sook Paek
Mu-Yong Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LG Chem Ltd
Original Assignee
LG Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LG Life Sciences Ltd filed Critical LG Life Sciences Ltd
Application granted granted Critical
Publication of DE60228324D1 publication Critical patent/DE60228324D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60228324T 2001-11-30 2002-11-29 Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem antibakteriellen carbapenem-mittel Expired - Lifetime DE60228324D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33513101P 2001-11-30 2001-11-30
PCT/KR2002/002247 WO2003045389A1 (en) 2001-11-30 2002-11-29 A method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent

Publications (1)

Publication Number Publication Date
DE60228324D1 true DE60228324D1 (de) 2008-09-25

Family

ID=23310394

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60228324T Expired - Lifetime DE60228324D1 (de) 2001-11-30 2002-11-29 Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem antibakteriellen carbapenem-mittel

Country Status (13)

Country Link
US (1) US20050020567A1 (de)
EP (1) EP1458390B1 (de)
AT (1) ATE404197T1 (de)
AU (1) AU2002360216A1 (de)
CA (1) CA2468033C (de)
CY (1) CY1108472T1 (de)
DE (1) DE60228324D1 (de)
DK (1) DK1458390T3 (de)
ES (1) ES2312654T3 (de)
MX (1) MXPA04005178A (de)
NO (1) NO331599B1 (de)
PT (1) PT1458390E (de)
WO (1) WO2003045389A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070061895A (ko) * 2004-10-08 2007-06-14 다이닛본 스미토모 세이야꾸 가부시끼가이샤 신규의 항균 약제
US9292565B2 (en) * 2010-06-30 2016-03-22 International Business Machines Corporation Template-based recognition of food product information

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080757A (en) * 1996-06-06 2000-06-27 Pfizer Inc Antibiotic quinolones and derivatives
EP1303256B1 (de) * 2000-06-09 2009-01-07 Baylor College of Medicine Kombination von antimikrobiellen wirkstoffen und bakterieller interferenz zum überziehen medizinischer vorrichtungen

Also Published As

Publication number Publication date
WO2003045389A1 (en) 2003-06-05
MXPA04005178A (es) 2004-08-11
EP1458390B1 (de) 2008-08-13
NO20042660L (no) 2004-06-24
NO331599B1 (no) 2012-02-06
ES2312654T3 (es) 2009-03-01
US20050020567A1 (en) 2005-01-27
EP1458390A4 (de) 2007-07-04
DK1458390T3 (da) 2008-12-15
PT1458390E (pt) 2008-10-02
EP1458390A1 (de) 2004-09-22
CA2468033A1 (en) 2003-06-05
AU2002360216A1 (en) 2003-06-10
CY1108472T1 (el) 2014-04-09
CA2468033C (en) 2008-02-12
ATE404197T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
PT759774E (pt) Metodo para o tratamento de infeccoes bacterianas gram-negativas por administracao de um produto de proteina bactericida indutora da permeabilidade (bip) e de um antibiotico
DE60326273D1 (de) Verfahren und verbindungen zur verstärkung der fybrozyten-bildung
ATE347277T1 (de) Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln
ATE247973T1 (de) Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
ATE427116T1 (de) Behandlung von bakteriellen infektionen
DE60126829D1 (de) Kombination von drei Substanzen zur Vorbeugung und Behandlung von Arthritis
DE60310400D1 (de) Botulinustoxine zur behandlung von priapismus
DE60219658D1 (de) Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης
DE602006006915D1 (de) Marrubin und zusammensetzung zur verringerung von schnarchen, verpackung und verfahren
ATE401888T1 (de) Verwendung von tigecyclin, allein oder in kombination mit rifampin zur behandlung von osteomyelitis und/oder septischer arthritis
DE60228324D1 (de) Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem antibakteriellen carbapenem-mittel
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE60137459D1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
WO2005053613A3 (en) Combinations for the treatment of fungal infections
EP1482958A4 (de) Verfahren zur behandlung, prävention oder hemmung von enterotoxigenen infektionen mit escherichia coli mit rindererythrozyten-präparaten
DE60233353D1 (de) Verfahren zur behandlung von halitose
TW200708309A (en) Antibacterial treatment and composition
WO2003101393A3 (en) Antibacterial compounds and methods for treating gram positive bacterial infections
DE69906729D1 (de) Zusammensetzung und methode zur behandlung von pseudomonas aeruginosa infektionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition